It is an exciting time to follow the new developments in the field of biotechnology and its wider applications in the different areas. The whole genomes of over 1000 viruses and over 100 microbes can now be found in Entrez Genome. The genomes represent both completely sequenced organisms and those for which sequencing is still in progress. The three main domains of life - bacteria, archaea, and eukaryota - are represented, as well as many viruses and organelles. The exponential increase of the sequence data lead to the development of the new "Bioinformatics" field in order to attempt making sense, at least biological sense, out of all the new and fast data.It will take also other techniques such as "functional genomics" to link the gap between a specific phenotype or a treatment and a gene sequence. Functional genomics tools are therefore important for the accurate molecular diagnosis/prognosis, target discovery validation needed for drug development and novel targets for antibiotics development. Functional genomics are also important for the confirmation of therapy in pharmacogenomics studies. Biotechnology is in many respects shaping our life and affecting our means of production and the creation of jobs. Progress in the applications of biotechnology depends on a wide base of basic as well as applied sciences. The output of biotechnology has already proved itself in many diverse fields from health tobiomining and from agriculture to enzyme "breeding". It is therefore difficult to follow all of the current as well as the potential applications of biotechnology.The objective of the Biotechnology Annual Review series is to attempt to provide readers with the needed indepth knowledge, by reviewing specific topics in biotechnology in each issue. The philosophy behind this series is to encourage good reviews to make it easier for readers to keep in touch with progress and applications of biotechnology. Reviews on topics related to regulatory affairs, social impact of biotechnology, biodiversity, biosafety, public acceptance and patent issues are also encouraged.
Author(s): M.R. El-Gewely
Series: Biotechnology Annual Review 9
Edition: 1
Publisher: Elsevier, Academic Press
Year: 2003
Language: English
Pages: 1-422
Content:
Preface
Pages v-vi
EDITORIAL BOARD FOR VOLUME 9
Pages vii-viii
List of contributors
Pages ix-x
Contents
Page xi
Biochips beyond DNA: technologies and applications Review Article
Pages 1-149
Jocelyn H Ng, Leodevico L Ilag
Non-ribosomal peptide synthetases as technological platforms for the synthesis of highly modified peptide bioeffectors – Cyclosporin synthetase as a complex example Review Article
Pages 151-197
Tony Velkov, Alfons Lawen
Horseradish peroxidase: a valuable tool in biotechnology Review Article
Pages 199-247
Ana M. Azevedo, Verónica C. Martins, Duarte M.F. Prazeres, Vojislav Vojinović, Joaquim M.S. Cabral, Luís P. Fonseca
in vitro diagnostic tests for infectious agents Considerations for the planning and conduct of reproducibility studies of in vitro diagnostic tests for infectious agents Review Article
Pages 249-258
Toniann Derion
Clinical trial methods to discover and validate predictive markers for treatment response in cancer Review Article
Pages 259-267
Soonmyung Paik
Production of high-quality marketing applications: strategies for biotechnology companies working with contract research organizations Review Article
Pages 269-277
Sandra J. Hecker, Christopher Preston, MaryAnn Foote
Use of benchmarking in the development of biopharmaceutical products Review Article
Pages 279-284
Marian Giffin, Sally McLeish
The state of biopharmaceutical manufacturing Review Article
Pages 285-302
David T. Molowa, Rosemary Mazanet
Review of current authorship guidelines and the controversy regarding publication of clinical trial data Review Article
Pages 303-313
MaryAnn Foote
Protein electrostatics: A review of the equations and methods used to model electrostatic equations in biomolecules – Applications in biotechnology Review Article
Pages 315-395
Maria Teresa Neves-Petersen, Steffen B. Petersen
The development of supportive-care agents for patients with cancer Review Article
Pages 397-417
Theresa K. Neumann, MaryAnn Foote
Index of authors
Page 419
Keyword index
Pages 421-422